AAV Vectors in Regenerative Medicine and Cellular Reprogramming: Potential, Pitfalls, and Specificity Constraints
International Journal of Molecular Sciences · 30.07.2026 · 27 (15) · 6846
DOI: 10.3390/ijms27156846 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.07.2026. Verfasst von Mariam Abdelnaby und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological and Medical Physics, Moscow Institute of Physics and Technology (State University), Institutskiy Per., 141701 Dolgoprudny, R…. Hauptthemen laut MEDLINE: Cellular Reprogramming, Regenerative Medicine, Genetic Vectors, Dependovirus. Die Arbeit nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
The adeno-associated virus (AAV) has become the vector of choice for gene therapy and experimental gene delivery, owing to its non-pathogenic nature and ability to achieve persistent gene expression across diverse tissues. AAV has emerged as a key platform in cellular reprogramming and regenerative medicine, with applications spanning transcription factor delivery for in vivo lineage conversion and tissue repair across the CNS, heart, and musculoskeletal systems. However, significant limitations remain, particularly in the context of induced pluripotent stem cell (iPSC) engineering. We assess barriers to efficient iPSC transduction including receptor-dependent entry deficits and activation of p53-dependent DNA damage responses. Although AAV is widely described as non-integrating, evidence indicates that integration events occur in rapidly proliferating and actively reprogramming cells. Critically, we synthesize evidence that cell-type-specific promoters lose fidelity when paired with neurogenic transgene payloads, a cross-tissue problem not addressed in existing AAV reviews, and that published in vivo reprogramming efficiencies may be substantially confounded by promoter leakage in the absence of formal lineage tracing. These aspects, underrepresented in recent platform-level reviews, are specifically emphasized here as a resource for researchers designing rigorous AAV-based reprogramming and gene therapy strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological and Medical Physics, Moscow Institute of Physics and Technology (State University), Institutskiy Per., 141701 Dolgoprudny, Russia.
- Research Institute of Translational Medicine, Pirogov Russian National Research Medical University, Ostrovitianov Street, 117997 Moscow, Russia.
- Research Institute of Molecular and Cellular Medicine, RUDN University, 117198 Moscow, Russia.
- Medical Institute, Banzarov Buryat State University, 670000 Ulan-Ude, Russia.
ORCID-Profile: Mariam Abdelnaby, Adelya Galiakberova, Erdem Dashinimaev
Förderung
- Russian Science Foundation
Zitieren
APA
Abdelnaby, M., Galiakberova, A., & Dashinimaev, E. (2026). AAV Vectors in Regenerative Medicine and Cellular Reprogramming: Potential, Pitfalls, and Specificity Constraints. International Journal of Molecular Sciences, 27(15), 6846. https://doi.org/10.3390/ijms27156846
Vancouver
Abdelnaby M, Galiakberova A, Dashinimaev E. AAV Vectors in Regenerative Medicine and Cellular Reprogramming: Potential, Pitfalls, and Specificity Constraints. International Journal of Molecular Sciences. 2026;27(15):6846. doi:10.3390/ijms27156846
BibTeX
@article{Abdelnaby2026,
author = {Abdelnaby, Mariam and Galiakberova, Adelya and Dashinimaev, Erdem},
title = {AAV Vectors in Regenerative Medicine and Cellular Reprogramming: Potential, Pitfalls, and Specificity Constraints},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {6846},
doi = {10.3390/ijms27156846}
}
EUVIMED